Quantcast

Latest NuPathe Inc. Stories

Migraine Skin Patch Approved By The FDA
2013-01-20 07:24:05

The Food and Drug Administration (FDA) has approved Zecuity, a skin patch used to treat migraine headaches, making it the first product of its kind to be cleared for sale in the US.

2008-07-24 09:00:25

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced that the company has raised $30 million in a recently completed Series B equity financing.

2008-06-30 12:02:03

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development.

2008-06-16 09:00:10

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced that Jane Hollingsworth, chief executive officer, will present at the Leerink Swann Emerging Technologies in Pain Conference at 2:00pm on June 23, 2008 at the Sofitel, New York Hotel located at 45 West 44th Street in NYC.

2008-01-08 09:00:19

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced that George Moonsammy, Ph.D. has been appointed Vice President of Development. Dr.

2007-01-16 09:01:38

CONSHOHOCKEN, Pa., Jan. 16 /PRNewswire/ -- NuPathe Inc., a privately held specialty pharmaceutical company, today announced the election of Michael Cola, president, Specialty Pharmaceutical Business, Shire Pharmaceuticals, to the NuPathe Board of Directors. Mr.


Word of the Day
bawbee
  • A coin originally worth six pennies Scots, and later three; held equivalent to an English halfpenny.
  • (in plural) Money; cash.
Related